Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Financials
Pharma
Daiichi Sankyo targets global top 5 oncology rank by 2035
By 2030, Daiichi envisions its revenues will reach more than 3 trillion yen ($19.1 billion), with 2.3 trillion yen from its oncology portfolio.
Angus Liu
May 11, 2026 10:22am
Gilead says long-acting PrEP Yeztugo in line for $1B in '26 sales
May 8, 2026 11:30am
Daiichi Sankyo takes $610M hit tied to ADC manufacturing losses
May 8, 2026 10:47am
Novo's Wegovy pill debuts with $355M in Q1
May 6, 2026 11:21am
White House touts $529B in MFN savings over 10 years
May 6, 2026 10:32am
BMS maintains Camzyos confidence amid Cytokinetics competition
Apr 30, 2026 2:20pm
